Summary The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …

Conventional radiographic skeletal survey has been for many years the gold standard to
detect the occurrence of osteolytic lesions in patients with multiple myeloma (MM). However …

Abstract Purpose FDG PET/CT is able to detect active disease in patients with multiple
myeloma (MM) and can be helpful for staging and assessing therapy response, but no …

The purpose of this study was to evaluate the clinical utility of whole-body PET with 18F-FDG
in patients with multiple myeloma and related monoclonal diseases. Methods: Between July …

F18-fluorodeoxyglucose positron emission tomography (FDG-PET) is a powerful tool to
investigate the role of tumor metabolic activity and its suppression by therapy for cancer …

Aim The objective of this study was to analyze the prognostic value of 18 F-FDG PET/CT
after therapy in patients with multiple myeloma (MM). Patients and Methods One hundred …

We prospectively analyzed the prognostic relevance of positron emission tomography–
computed tomography (PET/CT) at diagnosis, after thalidomide-dexamethasone (TD) …

Recent advances in the treatment of multiple myeloma have increased the need for accurate
diagnosis of the disease. The detection of bone and bone marrow lesions is crucial in the …

Objective. Very little information is available regarding the diagnostic utility of positron
emission tomography with [18 F] fluorodeoxyglucose (FDG PET) in multiple myeloma. Our …

This prospective study was undertaken to investigate the appearance of multiple myeloma
on fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET). Furthermore …